Fengfeng Zhou
Overview
Explore the profile of Fengfeng Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
1702
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Xin R, Cheng Q, Chi X, Feng X, Zhang H, Wang Y, et al.
Genes (Basel)
. 2023 Dec;
14(12).
PMID: 38136991
A transcriptome profiles the expression levels of genes in cells and has accumulated a huge amount of public data. Most of the existing biomarker-related studies investigated the differential expression of...
12.
Lai Y, Xu D, Li K, Song L, Chen Y, Li H, et al.
Comput Biol Med
. 2023 Nov;
167:107613.
PMID: 37918259
Thyroid cancer is the most common type of endocrine system cancer. The pre-cancer and early stages are usually benign or slowly growing, and do not need invasive treatments. This study...
13.
Wang Y, Wang Z, Liu Y, Yu Q, Liu Y, Luo C, et al.
BMC Infect Dis
. 2023 Sep;
23(1):622.
PMID: 37735372
Background: Coronavirus disease 2019 (COVID-19) is a rapidly developing and sometimes lethal pulmonary disease. Accurately predicting COVID-19 mortality will facilitate optimal patient treatment and medical resource deployment, but the clinical...
14.
Duan M, Wang Y, Zhao D, Liu H, Zhang G, Li K, et al.
Brief Bioinform
. 2023 Jul;
24(4).
PMID: 37427963
Survival analysis is critical to cancer prognosis estimation. High-throughput technologies facilitate the increase in the dimension of genic features, but the number of clinical samples in cohorts is relatively small...
15.
Li X, Lv X, Li H, Zhang G, Long Y, Li K, et al.
Adv Biol (Weinh)
. 2023 Jul;
7(12):e2300189.
PMID: 37423953
This work hypothesizes that some genes undergo radically changed transcription regulations (TRs) in breast cancer (BC), but don't show differential expressions for unknown reasons. The TR of a gene is...
16.
Wang Y, Zhang R, Zhang S, Guo L, Zhou Q, Zhao B, et al.
Comput Biol Med
. 2023 Jul;
163:107187.
PMID: 37393787
Artificial intelligence (AI) has achieved significant progress in the field of drug discovery. AI-based tools have been used in all aspects of drug discovery, including chemical structure recognition. We propose...
17.
Lv X, Li X, Chen S, Zhang G, Li K, Wang Y, et al.
Genes (Basel)
. 2023 Jun;
14(6).
PMID: 37372321
: Colon cancer (CC) is common, and the mortality rate greatly increases as the disease progresses to the metastatic stage. Early detection of metastatic colon cancer (mCC) is crucial for...
18.
Zhou F, Liu Q, Qin Y, Liu W, Zhang L
J Hazard Mater
. 2023 May;
456:131717.
PMID: 37245369
Herein, L-cysteine (Cys) was modified on zero-valent iron (C-ZVI) by using a mechanical ball-milling method to improve the surface functionality and the Cr(VI) removal efficiency. Characterization results indicated that Cys...
19.
Li F, Liu S, Li K, Zhang Y, Duan M, Yao Z, et al.
Comput Biol Med
. 2023 May;
160:107030.
PMID: 37196456
Methylation is a major DNA epigenetic modification for regulating the biological processes without altering the DNA sequence, and multiple types of DNA methylations have been discovered, including 6mA, 5hmC, and...
20.
Duan M, Liu Y, Zhao D, Li H, Zhang G, Liu H, et al.
Comput Biol Chem
. 2023 Apr;
104:107858.
PMID: 37058814
Colon cancer is a common cancer type in both sexes and its mortality rate increases at the metastatic stage. Most studies exclude nondifferentially expressed genes from biomarker analysis of metastatic...